Answers are grounded in this paper and cite their sources.
Cellular engineering enhances CAR T cell eradication of solid tumors, suggesting improved cancer treatment strategies.
Two recent studies of CAR T cells targeting tumor-associated macrophages have shown that "armoring" these engineered cells with the ability to express the cytokine IL12 makes them more effective at eradicating solid tumors and leads to sustained remodeling of the immunosuppressive tumor microenvironment.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: